Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
23,289,305
-
Share change
-
-1,621,074
-
Total reported value
-
$156,499,504
-
Put/Call ratio
-
78%
-
Price per share
-
$6.72
-
Number of holders
-
121
-
Value change
-
-$10,052,450
-
Number of buys
-
52
-
Number of sells
-
38
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q4 2015
As of 31 Dec 2015,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,289,305 shares.
The largest 10 holders included
BlackRock Fund Advisors, VANGUARD GROUP INC, STATE STREET CORP, WASATCH ADVISORS INC, BlackRock Institutional Trust Company, N.A., MORGAN STANLEY, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, SABBY MANAGEMENT, LLC, and STONERIDGE INVESTMENT PARTNERS LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.